MARKET

KAPA

KAPA

KAIROS PHARMA LTD
AMEX
1.700
-0.020
-1.16%
After Hours: 1.750 +0.05 +2.94% 19:22 12/13 EST
OPEN
1.700
PREV CLOSE
1.720
HIGH
1.920
LOW
1.670
VOLUME
136.28K
TURNOVER
--
52 WEEK HIGH
4.000
52 WEEK LOW
1.220
MARKET CAP
21.83M
P/E (TTM)
-7.4561
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at KAPA last week (1202-1206)?
Weekly Report · 4d ago
Weekly Report: what happened at KAPA last week (1125-1129)?
Weekly Report · 12/02 12:50
Kairos Pharma selects IBN for corporate communications efforts
TipRanks · 11/26 13:40
Weekly Report: what happened at KAPA last week (1118-1122)?
Weekly Report · 11/25 12:36
Why Elastic Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
Benzinga · 11/22 10:29
Kairos Pharma, Ltd. Announces Dual Listing on Upstream to Enhance Global Trading Opportunities
Barchart · 11/19 17:52
Kairos Pharma approved to dual list on Upstream
Seeking Alpha · 11/19 13:55
Weekly Report: what happened at KAPA last week (1111-1115)?
Weekly Report · 11/18 12:32
More
About KAPA
Kairos Pharma, Ltd. is a clinical-stage biopharmaceutical company advancing therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. Its products consist of five pre-clinical or clinical-trial stage drug candidates developed by it and designed to target immune response, and two therapeutic agents developed by its Enviro Therapeutics, Inc. (Enviro) subsidiary and designed to increase anti-tumor response in conjunction with cancer therapies by addressing resistance to these agents. Its product portfolio includes a variety of technologies licensed by its Enviro subsidiary and consists of compositions and methods for treating diseases and conditions by targeting CD105 and depleting mitochondrial DNA from the circulation. Its products include KROS 101, 102, 201, 301, 401, ENV 105 and 205.

Webull offers Kairos Pharma Ltd stock information, including AMEX: KAPA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KAPA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KAPA stock methods without spending real money on the virtual paper trading platform.